Development of guanylate cyclase activators for the treatment of pulmonary arterial hypertension
Development of guanylate cyclase activators for the treatment of pulmonary arterial hypertension
开发治疗肺动脉高压的鸟苷酸环化酶激活剂
批准号：
nhmrc : 472708
负责人：
Prof David Kaye
金额：
$9.18万
依托单位国家：
澳大利亚
项目类别：
NHMRC Development Grants
财政年份：
2008
资助国家：
澳大利亚
项目状态：
已结题
起止时间：
2008-01-01 至 2009-12-31
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Pulmonary arterial hypertension (PAH) is a life threatening condition with few treatment options. It is marked by shortness of breath and reduced energy as a result of an unexplained constriction of the blood vessels in the lung. This results in reduced life expectancy. We are developing a new treatment that will relax the blood vessels in the lung to improve quality and length of life.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Improving outcomes in heart failure through basic, clinical and translational research
-
批准号：nhmrc : 1136080
-
项目类别：Research Fellowships
-
资助金额：$64.23万
-
财政年份：2018
-
负责人：Prof David Kaye
-
依托单位：
Improving outcomes in heart failure through basic, clinical and translational research
-
批准号：nhmrc : GNT1136080
-
项目类别：Research Fellowships
-
资助金额：$95.1万
-
财政年份：2018
-
负责人：Prof David Kaye
-
依托单位：
Development of an extended release oral formulation of milrinone for patients with advanced heart failure
-
批准号：nhmrc : 1055647
-
项目类别：Development Grants
-
资助金额：$31.15万
-
财政年份：2013
-
负责人：Prof David Kaye
-
依托单位：
Integrated basic and clinical cardiovascular research for the development of innovative approaches to the treatment of heart failure
-
批准号：nhmrc : 1042495
-
项目类别：Research Fellowships
-
资助金额：$61.7万
-
财政年份：2013
-
负责人：Prof David Kaye
-
依托单位：
Manipulation of intracellular arginine content in endothelial cells
-
批准号：nhmrc : 367611
-
项目类别：NHMRC Project Grants
-
资助金额：$31.76万
-
财政年份：2006
-
负责人：Prof David Kaye
-
依托单位：
Congestive Heart Failure (CHF)
-
批准号：nhmrc : 225111
-
项目类别：NHMRC Research Fellowships
-
资助金额：$38.14万
-
财政年份：2003
-
负责人：Prof David Kaye
-
依托单位：
海外基金
